Table 1– Sit-to-stand (STS) and handgrip strength tests at baseline
STS testHandgrip strength test
Sample sizeNumber of repetitionsSample sizekg
All patients37418.9±8.840935.8±12.1
Sex
 Male21220.3±9.523342.8±10.1
 Female16217.2±7.417626.5±7.3
GOLD stage
 II24319.2±8.626135.7±12.3
 III8018.8±9.78934.9±12.7
 IV5117.9±8.05937.6±10.3
MRC dyspnoea
 06824.6±9.27142.7±12.1
 114921.3±8.715536.5±11.8
 24017.7±6.24136.4±11.3
 33713.7±4.84231.5±10.4
 48012.8±5.610031.3±11.1
Number of comorbidities
 0–216819.9±8.617837.7±12.0
 3–411218.4±8.312834.8±12.4
 ≥59417.8±9.510333.8±12.9
  • Data are presented as n or mean±sd. GOLD: Global Initiative for Chronic Obstructive Lung Disease; MRC: Medical Research Council.